Keywords: medarex, rises, 1m, medimmune, fee, shares, jumped
Medarex rises 2.9% on $1M MedImmune fee
Article | 09 February 2009
Shares in Medarex jumped 2.9% in afternoon trading on February 2, after the US biotechnology firm received a $1.0 million milestone from MedImmune, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
